Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gang Liang

Showing results (331-340 of 360) with videos related to

Pageof 36
Sort By:
Oncotarget|April 21, 2017
Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cellsYan Wen, Rui-Qiang Zhao, Yun-Kai Zhang, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|October 1, 2018
Cochlea sparing with a stratified scheme of dose limitation employed in intensity-modulated radiotherapy for nasopharyngeal carcinoma: A dosimetry studyChao Zhang, Ling-Xiang Liu, Wei-Zhan Li, et al.
Journal of Ethnopharmacology|July 5, 2020
The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expressionHuan Zhou, Li-Xiang Fu, Li Li, et al.
Innovation (Cambridge (Mass.))|September 11, 2020
Early Research on COVID-19: A Bibliometric AnalysisYue Gong, Ting-Can Ma, Yang-Yang Xu, et al.
Acta Pharmaceutica Sinica. B|April 12, 2019
The epigallocatechin gallate derivative Y<sub>6</sub> reverses drug resistance mediated by the ABCB1 transporter both <i>in vitro</i> and <i>in vivo</i>Yan Wen, Ruiqiang Zhao, Pranav Gupta, et al.
EJNMMI Research|December 22, 2025
<sup>18</sup>F-FAPI PET/CT imaging in pneumoconiosis: a pilot study on a novel tool for early diagnosis and guiding the treatment of pulmonary fibrosisChaofeng Liu, Zhongyuan Guo, Yiwei Shi, et al.
Nanophotonics (Berlin, Germany)|December 5, 2024
Independent and dynamic manipulation of surface waves radiation for quadruplex polarization channels enabled by programmable coding metasurfaceZhenxu Wang, Tonghao Liu, Jian-Gang Liang, et al.
Health and Quality of Life Outcomes|August 23, 2025
Validation and comparison of EQ-5D-5L and SF-6Dv1 in myopic patients requiring corneal refractive surgery in ChinaGang Liang, Ai-Xue Zhang, Fang-Yu Li, et al.
Molecular Immunology|August 1, 2009
Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicityDong Hua, Meng-Yuan Liu, Zhi-de Cheng, et al.
Pharmacogenetics and Genomics|June 23, 2005
Common genetic polymorphisms in the 5'-flanking region of the SULT1A1 gene: haplotypes and their association with platelet enzymatic activityBaitang Ning, Susan Nowell, Carol Sweeney, et al.
Pageof 36

Showing results (331-340 of 360) with videos related to

Sort By:
Pageof 36
Oncotarget|April 21, 2017
Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cellsYan Wen, Rui-Qiang Zhao, Yun-Kai Zhang, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|October 1, 2018
Cochlea sparing with a stratified scheme of dose limitation employed in intensity-modulated radiotherapy for nasopharyngeal carcinoma: A dosimetry studyChao Zhang, Ling-Xiang Liu, Wei-Zhan Li, et al.
Journal of Ethnopharmacology|July 5, 2020
The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expressionHuan Zhou, Li-Xiang Fu, Li Li, et al.
Innovation (Cambridge (Mass.))|September 11, 2020
Early Research on COVID-19: A Bibliometric AnalysisYue Gong, Ting-Can Ma, Yang-Yang Xu, et al.
Acta Pharmaceutica Sinica. B|April 12, 2019
The epigallocatechin gallate derivative Y<sub>6</sub> reverses drug resistance mediated by the ABCB1 transporter both <i>in vitro</i> and <i>in vivo</i>Yan Wen, Ruiqiang Zhao, Pranav Gupta, et al.
EJNMMI Research|December 22, 2025
<sup>18</sup>F-FAPI PET/CT imaging in pneumoconiosis: a pilot study on a novel tool for early diagnosis and guiding the treatment of pulmonary fibrosisChaofeng Liu, Zhongyuan Guo, Yiwei Shi, et al.
Nanophotonics (Berlin, Germany)|December 5, 2024
Independent and dynamic manipulation of surface waves radiation for quadruplex polarization channels enabled by programmable coding metasurfaceZhenxu Wang, Tonghao Liu, Jian-Gang Liang, et al.
Health and Quality of Life Outcomes|August 23, 2025
Validation and comparison of EQ-5D-5L and SF-6Dv1 in myopic patients requiring corneal refractive surgery in ChinaGang Liang, Ai-Xue Zhang, Fang-Yu Li, et al.
Molecular Immunology|August 1, 2009
Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicityDong Hua, Meng-Yuan Liu, Zhi-de Cheng, et al.
Pharmacogenetics and Genomics|June 23, 2005
Common genetic polymorphisms in the 5'-flanking region of the SULT1A1 gene: haplotypes and their association with platelet enzymatic activityBaitang Ning, Susan Nowell, Carol Sweeney, et al.
Pageof 36